NCT02164734View on ClinicalTrials.gov

Surfactant Via Endotracheal Tube vs. Laryngeal Mask Airway (LMA) in Preterm Neonates With Respiratory Distress Syndrome

PHASE4TerminatedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

May 20, 2020

Study Completion Date

December 31, 2020

Conditions
Respiratory Distress Syndrome, Newborn
Interventions
DEVICE

Endotracheal intubation

DEVICE

Laryngeal mask airway

DRUG

remifentanil

additional premedication in the endotracheal intubation/INSURE arm

Trial Locations (1)

12208

Albany Medical Center, Albany

Sponsors
All Listed Sponsors
collaborator

University of Rochester

OTHER

collaborator

ONY

INDUSTRY

lead

Albany Medical College

OTHER

NCT02164734 - Surfactant Via Endotracheal Tube vs. Laryngeal Mask Airway (LMA) in Preterm Neonates With Respiratory Distress Syndrome | Biotech Hunter | Biotech Hunter